Concepedia

Inhalation Dosage Forms

Inhalation Dosage Forms is a pharmaceutical formulation designed for pulmonary delivery, distinguished by its route of administration through the respiratory tract to achieve local or systemic therapeutic effects via inhalation.

5K

Publications

246.2K

Citations

16.9K

Authors

3.7K

Institutions

Publications per year

2017–2026

765

Variants

Inhaled Dosage Forms

Parents

Children

Publications

5K

Inhaled Iloprost for Severe Pulmonary Hypertension

Horst Olschewski, Gérald Simonneau, Nazzareno Galiè et al. · New England Journal of Medicine · 2002 · 1.8K citations · Full text

, , +12

Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial

PS Burge · BMJ · 2000 · 1.7K citations · Full text

, , +17

Effect of Inhaled Formoterol and Budesonide on Exacerbations of Asthma

Romain Pauwels, Claes-Göran Löfdahl, Dirkje S. Postma et al. · New England Journal of Medicine · 1997 · 1.5K citations · Full text

, , +12

Intermittent Administration of Inhaled Tobramycin in Patients with Cystic Fibrosis

Bonnie W. Ramsey, Margaret S. Pepe, Joanne Quan et al. · New England Journal of Medicine · 1999 · 1.3K citations · Full text

, , +15

Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD

David A. Lipson, Frank Barnhart, Noushin Brealey et al. · New England Journal of Medicine · 2018 · 1.3K citations · Full text

, , +17

1–5 of 5K

Authors

16.9K

  1. HC
    Hak‐Kim Chan

    The University of Sydney, Australia

    96 publications · 5.5K citations

    46

    h-index

  2. PM
    Paul M. Young

    The University of Sydney, Australia

    77 publications · 3K citations

    33

    h-index

  3. DT
    Daniela Traini

    The University of Sydney, Australia

    70 publications · 2.6K citations

    31

    h-index

  4. BJ
    Brian J. Lipworth

    Ninewells Hospital, United Kingdom

    42 publications · 2.1K citations

    27

    h-index

  5. HW
    Henderik W. Frijlink

    University of Groningen, Netherlands

    41 publications · 1.7K citations

    27

    h-index

1–5 of 16.9K

Institutions

3.7K

  1. The University of Sydney

    Sydney, Australia

    56 h-index

    582 publications

    30.7K citations

  2. AstraZeneca (Sweden)

    Södertälje, Sweden

    45 h-index

    303 publications

    22.4K citations

  3. Research Triangle Park Foundation

    Durham, United States

    37 h-index

    238 publications

    18.3K citations

  4. GlaxoSmithKline (United Kingdom)

    London, United Kingdom

    37 h-index

    272 publications

    35K citations

  5. University of North Carolina at Chapel Hill

    Chapel Hill, United States

    36 h-index

    171 publications

    9.4K citations

  6. University of Groningen

    Groningen, The Netherlands

    34 h-index

    234 publications

    10.6K citations

  7. Lund University

    Lund, Sweden

    34 h-index

    83 publications

    6.6K citations

  8. McMaster University

    Hamilton, Canada

    33 h-index

    146 publications

    9.5K citations

1–8 of 3.7K

Venues

  1. European Respiratory Journal

    165 publications · 12.6K citations

    63

    h-index

  2. International Journal of Pharmaceutics

    270 publications · 12.3K citations

    63

    h-index

  3. Thorax

    136 publications · 9.9K citations

    60

    h-index

  4. CHEST Journal

    158 publications · 9.7K citations

    57

    h-index

  5. Respiratory Medicine

    201 publications · 9K citations

    52

    h-index

1–5